Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily P McQuarrie

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 6, 2018
Anti-phospholipase A2 receptor antibodies in primary membranous nephropathy-10 key pointsEmily P McQuarrie
Clinical Kidney Journal|October 6, 2018
Renal biopsy: it is time for pragmatism and consensusJennifer S Lees, Emily P McQuarrie, Bruce Mackinnon
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 12, 2011
Idiopathic membranous nephropathy and nephrotic syndrome: outcome in the era of evidence-based therapyEmily P McQuarrie, Catherine M Stirling, Colin C Geddes
Current Opinion in Nephrology and Hypertension|February 27, 2022
Seven suggestions for successful SGLT2i use in glomerular disease - a standalone CKD therapy?Emily P McQuarrie, Keith A Gillis, Patrick B Mark
Journal of Renal Care|July 1, 2010
Cardiovascular disease in renal transplant recipientsEmily P McQuarrie, Bengt C Fellström, Hallvard Holdaas, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 29, 2009
Membranous nephropathy remains the commonest primary cause of nephrotic syndrome in a northern European Caucasian populationEmily P McQuarrie, Bruce Mackinnon, Graham A Stewart, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 6, 2010
Fractional excretions of albumin and IgG are the best predictors of progression in primary glomerulonephritisEmily P McQuarrie, Loai Shakerdi, Alan G Jardine, et al.
Seminars in Dialysis|February 7, 2014
How is the heart best protected in chronic dialysis patients?: Is there life in the old drugs yet? Mineralocorticoid receptor antagonism for cardiovascular prevention in chronic dialysis patientsPatrick B Mark, Alison H M Taylor, Emily P McQuarrie, et al.
Kidney International|August 30, 2014
The authors replyEmily P McQuarrie, Bruce Mackinnon, Valerie McNeice, et al.
Kidney International|September 13, 2013
The incidence of biopsy-proven IgA nephropathy is associated with multiple socioeconomic deprivationEmily P McQuarrie, Bruce Mackinnon, Valerie McNeice, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 6, 2018
Anti-phospholipase A2 receptor antibodies in primary membranous nephropathy-10 key pointsEmily P McQuarrie
Clinical Kidney Journal|October 6, 2018
Renal biopsy: it is time for pragmatism and consensusJennifer S Lees, Emily P McQuarrie, Bruce Mackinnon
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 12, 2011
Idiopathic membranous nephropathy and nephrotic syndrome: outcome in the era of evidence-based therapyEmily P McQuarrie, Catherine M Stirling, Colin C Geddes
Current Opinion in Nephrology and Hypertension|February 27, 2022
Seven suggestions for successful SGLT2i use in glomerular disease - a standalone CKD therapy?Emily P McQuarrie, Keith A Gillis, Patrick B Mark
Journal of Renal Care|July 1, 2010
Cardiovascular disease in renal transplant recipientsEmily P McQuarrie, Bengt C Fellström, Hallvard Holdaas, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 29, 2009
Membranous nephropathy remains the commonest primary cause of nephrotic syndrome in a northern European Caucasian populationEmily P McQuarrie, Bruce Mackinnon, Graham A Stewart, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 6, 2010
Fractional excretions of albumin and IgG are the best predictors of progression in primary glomerulonephritisEmily P McQuarrie, Loai Shakerdi, Alan G Jardine, et al.
Seminars in Dialysis|February 7, 2014
How is the heart best protected in chronic dialysis patients?: Is there life in the old drugs yet? Mineralocorticoid receptor antagonism for cardiovascular prevention in chronic dialysis patientsPatrick B Mark, Alison H M Taylor, Emily P McQuarrie, et al.
Kidney International|August 30, 2014
The authors replyEmily P McQuarrie, Bruce Mackinnon, Valerie McNeice, et al.
Kidney International|September 13, 2013
The incidence of biopsy-proven IgA nephropathy is associated with multiple socioeconomic deprivationEmily P McQuarrie, Bruce Mackinnon, Valerie McNeice, et al.
Pageof 4